[ Price : $8.95]
CBER sends Tri-State Biologics a notice of violation about selling amniotic/chorionic-based injectable products without a valid bi...[ Price : $8.95]
Forest sues Mylan over its ANDA for a generic form of Savella (milnacipran) tablets.[ Price : $8.95]
During a plenary presentation at an AdvaMed conference, FDA commissioner Margaret Hamburg promises increased cooperation and colla...[ Price : $8.95]
FDA awards more than $3.5 million in grants to seven pediatric medical device consortia to increase development and availability o...[ Price : $8.95]
FDA approves a new Boxed Warning for Arzerra and Rituxan about the risk of reactivation of hepatitis B infection.[ Price : $8.95]
Sunesis Pharmaceuticals completes enrollment of a Phase 3 VALOR trial of vosaroxin plus cytarabine in first relapsed or refractory...[ Price : $8.95]
Federal Register Notice: FDA releases a guidance: Mobile Medical Applications.[ Price : $8.95]
FDA grants orphan drug designation to Bayer HealthCare for its Adempas (riociguat) for treating pulmonary arterial hypertension an...